title: Group I secreted PLA2 and arachidonic acid metabolites in the maintenance of cat LES tone.
abstract: Spontaneous tone of in vitro lower esophageal sphincter (LES) circular muscle is associated with elevated levels of arachidonic acid (AA), PGF(2alpha), and increased [35S]guanosine 5'-O-(3-thiotriphosphate) (GTPgammaS) binding to Gq-, Gi3-, and G(i1/i2)-like G proteins. Tone and AA levels were reduced by inhibitors of a pancreatic-like (group I) secreted phospholipase A2 (sPLA2), by the cyclooxygenase inhibitor indomethacin, and by the thromboxane A2 antagonist SQ-29548. In addition, pertussis toxin (PTX) reduced LES tone, confirming a role of PTX-sensitive G proteins in maintenance of LES tone. PGF(2alpha) contracted LES smooth muscle (strips and cells) and increased [35S]GTPgammaS binding to Gq and Gi3 in solubilized LES circular muscle membranes. PGF(2alpha)-induced contraction of LES permeable muscle cells was inhibited by Gq and Gi3 but not by G(i1/i2) and Go antibodies. The thromboxane A2 analog U-46619 contracted LES smooth muscle and increased Gq binding. U-46619-induced contraction was inhibited by Gq but not by Gi3, G(i1/i2), and Go antibodies. LES tone and [(35)S]GTPgammaS binding were significantly reduced by indomethacin. We conclude that group I sPLA2 may mediate "spontaneous" LES tone by producing AA, which is metabolized to PGF(2alpha) and thromboxane A2. These AA metabolites activate receptors linked to Gi3 and Gq to maintain LES contraction.
authors.affiliation: Department of Medicine, Rhode Island Hospital and Brown University, Providence, Rhode Island 02902, USA.
authors.forename: W B
authors.initials: WB
authors.lastname: Cao
authors.forename: K M
authors.initials: KM
authors.lastname: Harnett
authors.forename: Q
authors.initials: Q
authors.lastname: Chen
authors.forename: M K
authors.initials: MK
authors.lastname: Jain
authors.forename: J
authors.initials: J
authors.lastname: Behar
authors.forename: P
authors.initials: P
authors.lastname: Biancani
mesh_terms: D000818:Animals; D016718:Arachidonic Acid / Q000378:metabolism*; D002415:Cats; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D015237:Dinoprost / Q000378:metabolism; D004943:Esophagogastric Junction / Q000187:drug effects / Q000502:physiology*; D004947:Esophagus / Q000378:metabolism; D019204:GTP-Binding Proteins / Q000502:physiology; D008297:Male; D009129:Muscle Tonus / Q000187:drug effects / Q000502:physiology*; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology*; D010741:Phospholipases A / Q000378:metabolism*; D054467:Phospholipases A2; D013931:Thromboxanes / Q000378:metabolism
chemical_list: D016861:Cyclooxygenase Inhibitors; D013931:Thromboxanes; D016718:Arachidonic Acid; D015237:Dinoprost; D010741:Phospholipases A; D054467:Phospholipases A2; D019204:GTP-Binding Proteins